Lumbosacral Radiculopathy study: VER-01
Official title Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
ClinicalTrials.gov ID: NCT06956014
What this study is testing
What is VER-01?
VER-01 is an investigational liquid medicine being studied to see if it helps with chronic lower back and leg pain. is designed to interact with the body's cannabinoid receptors, which are part of the system that helps regulate pain signals.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether VER-01 can reduce pain and improve safety compared to a pretend treatment in people with chronic painful lower back and leg pain.
- Who it's for
- You may be able to join if you have chronic painful lower back and leg pain that hasn’t improved with other medicines.
- What's involved
- You will receive either VER-01 or a pretend treatment. You will have visits and tests to check your pain and safety.
- Time commitment
- The study lasts several weeks and includes multiple visits to the clinic for treatment and follow‑up.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants ≥ 18 years of age, all sexes
- Participant voluntarily provided written informed consent
- Participant is willing and able to comply with scheduled visits, treatment plan, eDiary, and other trial-related procedures throughout trial...
You likely can't join if
- Pregnant or breastfeeding female patients
- Known history of previous or current severe psychiatric disorder as per DSM-5 (e.g., schizophrenia, bipolar disorder, severe anxiety disorder...
- Cardiovascular event or clinically significant cardiac dysfunction (e.g., congestive heart failure, myocardial ischemia, arrhythmias, poorly...
The study team makes the final eligibility decision.
Where it is enrolling
- Mobile, Alabama, United States
- Tempe, Arizona, United States
- Long Beach, California, United States
- Longmont, Colorado, United States
- Bradenton, Florida, United States
- Hialeah, Florida, United States
- Jacksonville, Florida, United States
- Maitland, Florida, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Pembroke Pines, Florida, United States
- Port Orange, Florida, United States
- Winter Park, Florida, United States
- Wichita, Kansas, United States
- Springfield, Massachusetts, United States
- Monroe, North Carolina, United States
- Winston-Salem, North Carolina, United States
- Cleveland, Ohio, United States
- Chickasha, Oklahoma, United States
- Medford, Oregon, United States
+ 11 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Mobile, Alabama, United States; Tempe, Arizona, United States; Long Beach, California, United States; Longmont, Colorado, United States; Bradenton, Florida, United States; Hialeah, Florida, United States and 25 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.